BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24345609)

  • 1. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
    Chakraborty S; Bose M; Sarkar M
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone.
    Roy S; Banerjee R; Sarkar M
    J Inorg Biochem; 2006 Aug; 100(8):1320-31. PubMed ID: 16684565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure.
    Chakraborty S; Sehanobish E; Sarkar M
    J Biol Inorg Chem; 2012 Mar; 17(3):475-87. PubMed ID: 22270943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectroscopic studies on the interaction of DNA with the copper complexes of NSAIDs lornoxicam and isoxicam.
    Goswami S; Ray S; Sarkar M
    Int J Biol Macromol; 2016 Dec; 93(Pt A):47-56. PubMed ID: 27554932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)-isoxicam, -meloxicam and -cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex.
    Cini R; Tamasi G; Defazio S; Hursthouse MB
    J Inorg Biochem; 2007 Aug; 101(8):1140-52. PubMed ID: 17592742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
    Mondal Roy S; Sarkar M
    Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of non steroidal anti-inflammatory drug induced membrane fusion by copper coordination of these drugs: anchoring effect.
    Majumdar A; Chakraborty S; Sarkar M
    J Phys Chem B; 2014 Dec; 118(48):13785-99. PubMed ID: 25380501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.
    Aman F; Hanif M; Kubanik M; Ashraf A; Söhnel T; Jamieson SM; Siddiqui WA; Hartinger CG
    Chemistry; 2017 Apr; 23(20):4893-4902. PubMed ID: 28198061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs.
    Chakraborty H; Roy S; Sarkar M
    Chem Phys Lipids; 2005 Dec; 138(1-2):20-8. PubMed ID: 16183046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of copper(II) with the non-steroidal anti-inflammatory drugs naproxen and diclofenac: synthesis, structure, DNA- and albumin-binding.
    Dimiza F; Perdih F; Tangoulis V; Turel I; Kessissoglou DP; Psomas G
    J Inorg Biochem; 2011 Mar; 105(3):476-89. PubMed ID: 20926136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam.
    Banerjee R; Chakraborty H; Sarkar M
    Spectrochim Acta A Mol Biomol Spectrosc; 2003 Apr; 59(6):1213-22. PubMed ID: 12659890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of a common painkiller piroxicam and copper-piroxicam with chromatin causes structural alterations accompanied by modulation at the epigenomic/genomic level.
    Goswami S; Sanyal S; Chakraborty P; Das C; Sarkar M
    Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):2048-2059. PubMed ID: 28411076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro DNA binding studies of the sweetening agent saccharin and its copper(II) and zinc(II) complexes.
    Icsel C; Yilmaz VT
    J Photochem Photobiol B; 2014 Jan; 130():115-21. PubMed ID: 24316657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)-piroxicam and -isoxicam complex molecules.
    Tamasi G; Serinelli F; Consumi M; Magnani A; Casolaro M; Cini R
    J Inorg Biochem; 2008 Oct; 102(10):1862-73. PubMed ID: 18667239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro biological activity of copper(II) complexes with NSAIDs and nicotinamide: Characterization, DNA- and BSA-interaction study and anticancer activity.
    Jozefíková F; Perontsis S; Koňáriková K; Švorc Ľ; Mazúr M; Psomas G; Moncol J
    J Inorg Biochem; 2022 Mar; 228():111696. PubMed ID: 35030390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordination modes of bidentate lornoxicam drug with some transition metal ions. Synthesis, characterization and in vitro antimicrobial and antibreastic cancer activity studies.
    Mahmoud WH; Mohamed GG; El-Dessouky MM
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():598-608. PubMed ID: 24334061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper(II) complexes with the non-steroidal anti-inflammatory drug tolfenamic acid: Structure and biological features.
    Tarushi A; Perontsis S; Hatzidimitriou AG; Papadopoulos AN; Kessissoglou DP; Psomas G
    J Inorg Biochem; 2015 Aug; 149():68-79. PubMed ID: 25824465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.
    Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M
    J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, spectroscopic and DFT structural characterization of two novel ruthenium(III) oxicam complexes. In vivo evaluation of anti-inflammatory and gastric damaging activities.
    Tamasi G; Bernini C; Corbini G; Owens NF; Messori L; Scaletti F; Massai L; Giudice PL; Cini R
    J Inorg Biochem; 2014 May; 134():25-35. PubMed ID: 24518539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantiomeric in vitro DNA binding, pBR322 DNA cleavage and molecular docking studies of chiral L- and D-ternary copper(II) complexes of histidine and picolinic acid.
    Parveen S; Arjmand F; Ahmad I
    J Photochem Photobiol B; 2014 Jan; 130():170-8. PubMed ID: 24333765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.